is tirzepatide the same as manjaro Who Should NOT Use Tirzepatide?

Le tirzpatide est contre-indiqu : si vous tes hypersensible au tirzpatide ou aux excipients utiliss (alcool benzylique, acide chlorhydrique concentr)

Clinical data insights: In a large placebo-controlled trial, tesamorelin raised IGF-1 by 181% on average, but about 5% of participants discontinued due to adverse events, most commonly musculoskeletal pain and injection-site irritation (Falutz et al., NEJM )

While manageable for many, these issues can be more problematic after bariatric surgery, when the stomach is smaller and digestion is already altered

Ray 1999

Therefore, in case you have any unusual skin reactions, you should stop taking the supplement immediately